- Report
- August 2025
- 189 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- November 2025
- 160 Pages
Global
From €2962EUR$3,358USD£2,594GBP
€3485EUR$3,950USD£3,052GBP
- Report
- August 2025
- 180 Pages
Global
From €3128EUR$3,545USD£2,739GBP
€3475EUR$3,939USD£3,043GBP
- Report
- April 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- April 2025
- 200 Pages
Global
From €3961EUR$4,490USD£3,469GBP
- Report
- October 2025
- 160 Pages
Global
From €2962EUR$3,358USD£2,594GBP
€3485EUR$3,950USD£3,052GBP
- Report
- July 2024
- 100 Pages
Global
From €2647EUR$3,000USD£2,318GBP
€3308EUR$3,750USD£2,897GBP
- Report
- December 2023
- 1362 Pages
Global
From €8818EUR$9,995USD£7,721GBP
- Report
- May 2023
- 117 Pages
Global
From €3500EUR$4,250USD£3,172GBP
- Report
- May 2023
- 81 Pages
Global
From €3500EUR$4,250USD£3,172GBP
The Patent Foramen Ovale (PFO) Device market is a subset of the Cardiovascular Devices market. It is composed of medical devices used to close a hole in the heart, known as a patent foramen ovale (PFO). This hole is a natural opening between the two upper chambers of the heart, and it is present in about 25% of the population. PFO closure devices are used to reduce the risk of stroke and other neurological events. These devices are typically implanted during a minimally invasive procedure, and they are designed to remain in place for the lifetime of the patient.
The PFO Device market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Abbott, Boston Scientific, W.L. Gore & Associates, and Occlutech. Show Less Read more
